Show: 10 · 20 · 50

1. 1

• Esther Oh Lab

  The Esther Oh Lab is interested in developing biological markers for pre-clinical stages of Alzheimer's disease (AD). Our current research involves using transgenic models of AD to develop peripheral injections of monoclonal antibodies against amyloid-beta as a tool to detect a level of amyloid-beta that would be correlative to the amyloid-beta level in the brain.

  Research Areas: amyloid-beta, dementia, Alzheimer's disease, monoclonal antibodies

  

  Principal Investigator

  Esther Oh, M.D., Ph.D.

  Department

  Medicine
  

1. 1